综合多组学分析揭示了gypenosides对酸诱导的大肠炎的保护功能
Yuan Yang1, Xinyuan Li1, Fan Huang1
1Department of Gastroenterology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
Scientific reports
|August 28, 2025
概括
通过调节干细胞基因和代谢途径,Gypenosides有效治疗大肠炎. 这项研究表明,在小鼠模型中,gypenosides可缓解性结肠炎 (UC) 症状并促进粘膜修复.
科学领域:
- 胃肠病学
- 药理学
- 分子生物学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病.
- 目前对UC的治疗有局限性,需要新的治疗策略.
- 基化物是具有潜在抗炎功能的天然化合物.
研究的目的:
- 为了研究gypenosides对大肠炎的治疗效果.
- 通过多组学分析阐明性结肠炎 (UC) 治疗中的基因基因机制.
主要方法:
- 使用硫酸 (DSS) 建立了UC小鼠模型.
- 向UC小鼠的一小组注射了gypenosides.
- 进行了组织学,分子,转录组和代谢学分析.
- 使用免疫组织化学检测关键蛋白质.
主要成果:
- 在DSS诱导的UC小鼠中,用Gypenosides治疗显著缓解了临床症状,减少了结肠缩短,并降低了疾病活性指数 (DAI).
- 转录组分析发现肠干细胞基因Ascl2和Lgr5的差异表达.
- 代谢学发现三碳酸循环 (TCA) 和氨基酸代谢 (AM) 途径的改变.
结论:
- 基化物对结肠炎具有治疗潜力,可能通过调节干细胞活性.
- 这种机制涉及调节与干性相关的基因以及TCA和氨基酸代谢等代谢途径.
- 催化剂促进受损结肠粘膜的修复,为UC治疗提供了一个有前途的途径.
相关概念视频
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.6K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
1.1K
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
1.1K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.3K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
1.0K
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K
Peptic Ulcer Disease IV: Management
807
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
807


